Burning Rock Biotech Ltd (BNR) Institutional Ownership

Ownership Summary

The institutional landscape for Burning Rock Biotech Ltd (NASDAQ:BNR) includes 15 filers as of the latest reporting cycle ending September 2025.

• Institutional ownership in Burning Rock Biotech edged down to 1.3% in September 2025, compared to 1.3% in June 2025.
• The company experienced a 2.94% quarterly change in institutional shares held, alongside a decrease of 16.67% in total owners annually.
• The latest 13F cycle for Burning Rock Biotech reveals that of 15 total investors, 6 funds grew their exposure, whereas 3 reduced theirs and 6 made no changes.
• This class of investors increased its holdings in Burning Rock Biotech to 1.42Mn shares for the 13F-cycle ending September 2025, up by 40.52K shares quarter on quarter, and down 626.46K shares year over year.
• As of September 30, 2025, Kynam Capital Management, LP held Burning Rock Biotech's largest shareholding position with over 994.88K shares, representing 0.92% of total outstanding shares.
• Among the most significant buyers of Burning Rock Biotech during September 2025 were CRCM LP (26.81K), Prospera Financial Services Inc (24.75K), MORGAN STANLEY (4.06K), China Universal Asset Management Co., Ltd. (3.00K), UBS Group AG (159).
• Leading sellers of Burning Rock Biotech stock in September 2025 included Sumitomo Mitsui Trust Group, Inc. (9.09K), Amova Asset Management Americas, Inc. (9.09K), BANK OF AMERICA CORP /DE/ (100).
• The top 10 institutional holders of Burning Rock Biotech for the quarter ending September 2025 included Kynam Capital Management, LP (994.88K), CRCM LP (221.57K), Sumitomo Mitsui Trust Group, Inc. (34.84K), Amova Asset Management Americas, Inc. (34.84K), RENAISSANCE TECHNOLOGIES LLC (31.72K), BANK OF AMERICA CORP /DE/ (29.18K), Prospera Financial Services Inc (24.75K), MORGAN STANLEY (22.27K), HSG Holding Ltd (21.21K), China Universal Asset Management Co., Ltd. (3.00K).